Cargando…
High leukocyte mitochondrial DNA copy number contributes to poor prognosis in breast cancer patients
BACKGROUND: Compelling evidence has indicated a significant association between leukocyte mitochondrial DNA copy number (mtDNAcn) and prognosis of several malignancies in a cancer-specific manner. However, whether leukocyte mtDNAcn can predict the clinical outcome of breast cancer (BC) patients has...
Autores principales: | Zhang, Wenzhe, Lin, Songping, Zeng, Bangwei, Chen, Xiaobin, Chen, Lili, Chen, Minyan, Guo, Wenhui, Lin, Yuxiang, Yu, Liuwen, Hou, Jialin, Li, Yan, Li, Shengmei, Jin, Xuan, Cai, Weifeng, Zhang, Kun, Nie, Qian, Chen, Hanxi, Li, Jing, He, Peng, Cai, Qindong, Qiu, Yibin, Wang, Chuan, Fu, Fangmeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131463/ https://www.ncbi.nlm.nih.gov/pubmed/37098487 http://dx.doi.org/10.1186/s12885-023-10838-x |
Ejemplares similares
-
Association of Adjuvant Hormone Therapy Timing With Overall Survival Among Patients With Hormone Receptor–Positive Human Epidermal Growth Factor Receptor-2–Negative Early Breast Cancer Without Chemotherapy
por: Fu, Fangmeng, et al.
Publicado: (2022) -
Clinical application of artificial neural network (ANN) modeling to predict BRCA1/2 germline deleterious variants in Chinese bilateral primary breast cancer patients
por: Li, Yan, et al.
Publicado: (2022) -
Impact of body mass index in therapeutic response for HER2 positive breast cancer treated with neoadjuvant targeted therapy: a multi-center study and meta-analysis
por: Chen, Lili, et al.
Publicado: (2023) -
HER2 copy number quantification in primary tumor and cell-free DNA provides additional prognostic information in HER2 positive early breast cancer
por: Chen, Xiaobin, et al.
Publicado: (2022) -
YTHDF3 facilitates triple-negative breast cancer progression and metastasis by stabilizing ZEB1 mRNA in an m(6)A-dependent manner
por: Lin, Yuxiang, et al.
Publicado: (2022)